F Rosner, H Grünwald. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AdultAgedAntineoplastic Agents/therapeutic useBone Marrow/pathologyBone Marrow CellsDrug Therapy, CombinationFemaleHematocritHemoglobins/analysisHumansImmunoglobulins/isolation & purificationLeukemia/chemically inducedLeukemia/complicationsLeukemia, Myeloid, Acute/complicationsLeukemia, Myeloid, Acute/diagnosisLeukemia, Myeloid, Acute/epidemiologyLeukemia, Myeloid, Acute/immunologyLeukemia, Myeloid, Acute/pathologyLeukocyte CountMaleMelphalan/administration & dosageMelphalan/adverse effectsMelphalan/therapeutic useMiddle AgedMultiple Myeloma/complicationsMultiple Myeloma/drug therapyPrednisone/therapeutic useRemission, SpontaneousSyndrome
Substances: See more » Antineoplastic AgentsHemoglobinsImmunoglobulinsMelphalanPrednisone
Year: 1974 PMID: 4611209 DOI: 10.1016/0002-9343(74)90171-5
Source DB: PubMed Journal: Am J Med ISSN: 0002-9343 Impact factor: 4.965